We employed MiTA to compare the antitumor activity of anti‐BCMA and APRIL‐based CAR T cells toward BCMA positive and negative multiple myeloma MM.1s tumor cells. The gene discussed is TNFRSF17; the disease is Miyoshi myopathy.